Michael C. Heinrich, M.D.

Head Shot of Michael Heinrich
Special Interests:
Gastrointestinal Stromal Tumors, Chronic Myeloid Leukemia
Accepting Patients:


Dr. Heinrich provides expert care for patients with gastrointestinal stromal tumors (GIST). He is one of a handful of GIST experts on the West Coast. As part of his research program, Dr. Heinrich has authored more than 30 papers on clinical and molecular aspects of GIST and helped design and conduct the Phase II and III studies that led to FDA approval of imatinib (Gleevec) and sunitinib (Sutent) for GIST. In addition, Dr. Heinrich’s GIST clinic offers clinical studies of investigational agents for patients with advanced disease and expert molecular diagnostic consultation.


Dr. Heinrich also specializes in head and neck cancer and participates in the multidisciplinary care of these patients with members of the OHSU ENT and radiation oncology departments.

Professional Education

  • Degree:
    M.D., Johns Hopkins University School of Medicine, 1984
  • Residency:

    Oregon Health & Science University, 1988

  • Fellowship:

    Hematology/Medical Oncology, Oregon Health & Science University, 1991

  • Certification:

    American Board of Internal Medicine, (Internal Medicine), 1987 American Board of Internal Medicine (Hematology), 1990 (Recertified 2010) American Board of Internal Medicine, (Medical Oncology), 1991 (Recertified 2011)


OHSU Knight Cancer Institute

Visit our site

Provider Referral Line

503 494-8311

I see patients at:

Center for Health & Healing

Insurance Information

OHSU accepts most insurance plans

Insurance Information